Monoclonal Antibodies Targeting Amyloid for Alzheimer Disease
296
0
2023-11-28 17:41
USPSTF Recommendation - Folic Acid Supplementation for Prevention of Neural Tube Defects
阿尔茨海默病神经影像学研究进展-李坤成
USPSTF Recommendations: Screening and Preventive Interventions for Oral Health
Management of Cirrhosis in 2023
USPSTF Recommendation - Screening for Latent Tuberculosis Infection in Adults
Cervical Cancer： The Importance of HPV Testing and Vaccination
USPSTF Recommendation - Preexposure Prophylaxis to Prevent Acquisition of HIV
Gestational Diabetes and Long-Term Cardiometabolic Health
0 bullet chats
Please Sign In first
LikesSend-PenFavorites
Scan by WeChatUnauthorized reproduction is prohibited
In this interview, dementia expert Gil D. Rabinovici, MD, discusses monoclonal antibodies that target beta-amyloid–-including a recent phase 3 trial of donanemab published in JAMA-–and reviews considerations for their use in patients with Alzheimer disease.
Comments 0
Please to post a comment~
Loading...
Related Suggestion